Compare CDNA & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | PNTG |
|---|---|---|
| Founded | 1998 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2014 | N/A |
| Metric | CDNA | PNTG |
|---|---|---|
| Price | $19.16 | $27.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $26.67 | ★ $35.33 |
| AVG Volume (30 Days) | ★ 750.2K | 218.0K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.47 |
| EPS | ★ 1.22 | 0.75 |
| Revenue | $357,998,000.00 | ★ $847,274,000.00 |
| Revenue This Year | $14.11 | $36.42 |
| Revenue Next Year | $11.75 | $23.99 |
| P/E Ratio | ★ $15.51 | $37.44 |
| Revenue Growth | 14.46 | ★ 29.89 |
| 52 Week Low | $10.96 | $21.18 |
| 52 Week High | $25.95 | $30.46 |
| Indicator | CDNA | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 54.20 | 41.70 |
| Support Level | $19.01 | $28.99 |
| Resistance Level | $20.61 | $29.91 |
| Average True Range (ATR) | 0.71 | 0.67 |
| MACD | -0.22 | -0.31 |
| Stochastic Oscillator | 18.43 | 9.21 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.